FDA monthly preview: Key October decisions to watch
-
By
-
Kathryn Wighton
-
September 25, 2026
-
5 min
By
Kathryn Wighton
September 25, 2026
Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.
May 29, 2026
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
by Kerri Miller
April 17, 2026